Cargando…
Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae
PURPOSE: Fluoroquinolones are recommended for the treatment of pneumonia. The recognition of risk factors for invasive levofloxacin-resistant Streptococcus pneumoniae is important for the design of treatment. METHODS: A retrospective review of cases of invasive pneumococcal infections in adults was...
Autores principales: | Isea-Peña, M. C., Sanz-Moreno, J. C., Esteban, J., Fernández-Roblas, R., Fernández-Guerrero, M. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102337/ https://www.ncbi.nlm.nih.gov/pubmed/23709294 http://dx.doi.org/10.1007/s15010-013-0481-4 |
Ejemplares similares
-
Role of PatAB Transporter in Efflux of Levofloxacin in Streptococcus pneumoniae
por: Amblar, Mónica, et al.
Publicado: (2022) -
Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine
por: Lo, Stephanie W., et al.
Publicado: (2018) -
Comparison of contemporary invasive and non-invasive Streptococcus pneumoniae isolates reveals new insights into circulating anti-microbial resistance determinants
por: Higgs, Charlie, et al.
Publicado: (2023) -
Assessment of Streptococcus pneumoniae pilus islet-1 prevalence in carried and transmitted isolates from mother–infant pairs on the Thailand–Burma border
por: Turner, P, et al.
Publicado: (2012) -
Reporting Emerging Resistance of Streptococcus pneumoniae from India
por: Chawla, Kiran, et al.
Publicado: (2010)